PI
-
Correction to: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial (Leukemia, (2024), 38, 4, (781-787), 10.1038/s41375-024-02145-6)
Flygt, H., Söderlund, S., Richter, J., Saussele, S., Koskenvesa, P., Stenke, L., Mustjoki, S., Dimitrijevic, A., Stentoft, J., Majeed, W., Roy, L., Wolf, D., Dreimane, A., Gjertsen, B. T., Gedde-Dahl, T., Ahlstrand, E., Markevärn, B., Hjorth-Hansen, H., Janssen, J. & Olsson-Strömberg, U., Apr 2024, In: Leukemia. 38, 4, p. 925 1 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
van de Loosdrecht, A. A., Cremers, E. M. P., Alhan, C., Duetz, C., in ’t Hout, F. E. M., Visser-Wisselaar, H. A., Chitu, D. A., Verbrugge, A., Cunha, S. M., Ossenkoppele, G. J., Janssen, J. J. W. M., Klein, S. K., Vellenga, E., Huls, G. A., Muus, P., Langemeijer, S. M. C., de Greef, G. E., te Boekhorst, P. A. W., Raaijmakers, M. H. G., van Marwijk Kooy, M., & 20 others , Apr 2024, In: Leukemia. 38, 4, p. 840-850 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial
Flygt, H., Söderlund, S., Richter, J., Saussele, S., Koskenvesa, P., Stenke, L., Mustjoki, S., Dimitrijevic, A., Stentoft, J., Majeed, W., Roy, L., Wolf, D., Dreimane, A., Gjertsen, B. T., Gedde-Dahl, T., Ahlstrand, E., Markevärn, B., Hjorth-Hansen, H., Janssen, J. & Olsson-Strömberg, U., Apr 2024, In: Leukemia. 38, 4, p. 781-787 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications